Depressive Disorders - Germany | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$888.60m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.61%, resulting in a market volume of US$915.90m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$253.40 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Germany has been experiencing significant growth in recent years.

Customer preferences: In Germany, there is a growing awareness and acceptance of mental health issues, including depressive disorders. The stigma surrounding mental health is gradually diminishing, leading to an increased willingness among individuals to seek help and treatment for their conditions. This has resulted in a higher demand for medications and therapies related to depressive disorders.

Trends in the market: One of the key trends in the Depressive Disorders market in Germany is the rising use of antidepressant medications. Healthcare professionals are prescribing antidepressants more frequently to patients suffering from depressive disorders. This trend is driven by several factors, including the effectiveness of these medications in managing symptoms and the increased accessibility of mental health services.Another trend in the market is the growing popularity of psychotherapy as a treatment option for depressive disorders. Many individuals in Germany prefer non-pharmacological approaches to managing their mental health, and psychotherapy provides a holistic and personalized treatment plan. This trend is also supported by the availability of qualified therapists and the inclusion of psychotherapy services in the German healthcare system.

Local special circumstances: Germany has a well-developed healthcare system that provides comprehensive coverage for mental health services. This includes access to psychiatrists, psychologists, and other mental health professionals. The government has also implemented initiatives to improve mental health care and reduce waiting times for treatment. These factors contribute to the growth of the Depressive Disorders market in Germany.Additionally, the aging population in Germany is a significant factor driving the demand for depressive disorder treatments. Older adults are more susceptible to depressive disorders, and as the population ages, there is an increased need for effective treatments and support services.

Underlying macroeconomic factors: Germany is one of the largest economies in Europe and has a high standard of living. The country's strong economy and high disposable income levels enable individuals to afford the cost of medications, therapies, and other treatments for depressive disorders. This economic stability contributes to the growth of the Depressive Disorders market in Germany.Furthermore, the COVID-19 pandemic has had a significant impact on mental health globally, including in Germany. The stress and uncertainty caused by the pandemic have led to an increase in mental health issues, including depressive disorders. As a result, there is a higher demand for treatments and support services in the Depressive Disorders market.In conclusion, the Depressive Disorders market in Germany is experiencing growth due to changing customer preferences, including a greater acceptance of mental health issues and a preference for non-pharmacological treatments. The availability of comprehensive healthcare coverage, a well-developed healthcare system, and the country's strong economy also contribute to this growth. The impact of the COVID-19 pandemic on mental health has further fueled the demand for treatments and support services in the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.